T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis

Mult Scler. 2009 Jun;15(6):678-86. doi: 10.1177/1352458509103611.

Abstract

Background: Gray matter (GM) magnetic resonance imaging (MRI) T2 hypointensity, a putative marker of iron deposition, commonly occurs in multiple sclerosis (MS). However, GM T2 hypointensity in benign MS (BMS) has not yet been characterized.

Objective: To determine the presence of deep GM T2 hypointensity in BMS, compare it to secondary progressive (SP) MS and assess its association with clinical and diffusion tensor (DT) MRI measures.

Methods: Thirty-five cognitively unimpaired BMS, 26 SPMS patients, and 25 healthy controls were analyzed for normalized T2-intensity in the basal ganglia and thalamus, global T2 hyperintense lesion volume, global atrophy, and white matter and GM DT metrics.

Results: BMS and SPMS patients showed deep GM T2 hypointensity compared with controls. T2 hypointensity was similar in both MS subgroups and moderately correlated (r = -0.45 to 0.42) with DT MRI metrics. GM T2 hypointensity in BMS showed a weak to moderate correlation (r = -0.44 to -0.35) with disability.

Conclusions: GM in BMS is not spared from structural change including iron deposition. However, while T2 hypointensity is related to global tissue disruption reflected in DT MRI, the expression of benign versus non-benign MS is likely related to other factors.

MeSH terms

  • Adult
  • Atrophy
  • Basal Ganglia / metabolism
  • Basal Ganglia / pathology*
  • Cognition
  • Diffusion Magnetic Resonance Imaging*
  • Disability Evaluation
  • Female
  • Humans
  • Iron / metabolism
  • Male
  • Middle Aged
  • Multiple Sclerosis / metabolism
  • Multiple Sclerosis / pathology*
  • Neurons / pathology*
  • Severity of Illness Index
  • Thalamus / metabolism
  • Thalamus / pathology*

Substances

  • Iron